AU2021902146A0 - Compositions for the Treatment of Diseases and Conditions - Google Patents

Compositions for the Treatment of Diseases and Conditions

Info

Publication number
AU2021902146A0
AU2021902146A0 AU2021902146A AU2021902146A AU2021902146A0 AU 2021902146 A0 AU2021902146 A0 AU 2021902146A0 AU 2021902146 A AU2021902146 A AU 2021902146A AU 2021902146 A AU2021902146 A AU 2021902146A AU 2021902146 A0 AU2021902146 A0 AU 2021902146A0
Authority
AU
Australia
Prior art keywords
diseases
compositions
treatment
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021902146A
Inventor
Gerrard Twomey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2021902146A0 publication Critical patent/AU2021902146A0/en
Abandoned legal-status Critical Current

Links

AU2021902146A 2021-07-14 Compositions for the Treatment of Diseases and Conditions Abandoned AU2021902146A0 (en)

Publications (1)

Publication Number Publication Date
AU2021902146A0 true AU2021902146A0 (en) 2021-07-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP3908374A4 (en) Compositions and methods for diagnosis and treatment of neurodegenerative diseases
EP3906043A4 (en) Methods and compositions for the treatment of fabry disease
EP3761970A4 (en) Compositions and methods for the treatment of neurological diseases
IL288375A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP3836965A4 (en) Compositions and methods of inhibiting masp-2 for the treatment of various thrombotic diseases and disorders
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
IL287802A (en) Compositions and methods for treatment of ocular diseases
GB202010464D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP4100406A4 (en) Compositions for treatment of ocular diseases
EP4034109A4 (en) Method and composition for the treatment of disease
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
EP3866790A4 (en) Methods and compositions for treatment of glaucoma and related conditions
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP4017873A4 (en) Compositions and methods for the treatment of pathological pain and itch
EP3877383A4 (en) Compounds and compositions for the treatment of respiratory diseases
EP3914263A4 (en) Methods and compositions for the treatment and prevention of ocular diseases and conditions
EP3917949A4 (en) Compositions and methods for treatment of diseases involving cxcl1 function
EP4087847A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
IL285751A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
AU2021902146A0 (en) Compositions for the Treatment of Diseases and Conditions
AU2020901573A0 (en) Compositions for the Treatment of Diseases and Conditions
EP4051260A4 (en) Methods and compositions for treatment of cancer
EP3917619A4 (en) Structurally modified opioids for prevention and treatment of diseases and conditions
EP3793522A4 (en) Compositions and methods for the treatment of inflammatory skin diseases and cancer
AU2019901644A0 (en) Compositions for the Treatment of Diseases and Conditions